Molnupiravir may not lower hospitalization or mortality but hastens recovery in vaccinated COVID-19 patients: Lancet Dr. Kamal Kant Kohli24 Dec 2022 11:30 AM ISTResearchers have found in a new randomised controlled trial that Molnupiravir taken as an 800mg dose twice daily for five days may not lower...
Azithromycin no better than placebo among patients of LRTI with low procalcitonin levels: Lancet Dr.Niharika Harsha B19 Dec 2022 8:00 PM ISTA recent trial found that in adults with lower respiratory tract infections and lower procalcitonin concentration, the placebo was not non-inferior to...
Lorecivivint promising treatment option for knee osteoarthritis, interim findings from trial reveal Dr. Kamal Kant Kohli17 Dec 2022 9:30 AM ISTUSA: Repeated injections of the lorecivivint (LOR) in knee osteoarthritis patients may slow the decline of medial joint space width, according to...
Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet Dr. Kamal Kant Kohli12 Dec 2022 10:45 AM ISTRocatinlimab is a novel, patient-tailored monoclonal antibody therapy. Role of rocatinlimab as a safe and effective treatment for atopic...
ivermectin effective in outpatients with mild to moderate COVID-19 Dr. Shravani Dali10 Dec 2022 8:00 PM ISTIvermectin effective in treating outpatients with mild to moderate COVID-19 suggests a recent study published in the JAMA. The effectiveness of...
Lebrikizumab as safe as placebo among adults and adolescents with uncontrolled asthma Dr. Kamal Kant Kohli27 Nov 2022 8:00 PM ISTU.S.A: According to research findings presented at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting,...
Ivermectin unable to significantly trim the time to recovery in COVID-19 patients: JAMA Dr.Niharika Harsha B28 Oct 2022 12:00 PM ISTA new trial conducted in the US found that Ivermectin could not reduce the time to recovery in mild-to-moderate COVID-19 patients when compared with a...
Olokizumab superior to placebo and noninferior to adalimumab in RA patients Dr. Shravani Dali22 Sept 2022 8:30 PM ISTIn patients with rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo and noninferior to adalimumab...
Olokizumab Outperforms Placebo in RA patients on maintenance Methotrexate: NEJM Dr. Kamal Kant Kohli29 Aug 2022 8:00 AM ISTVIENNA: Patients with rheumatoid arthritis taking maintenance methotrexate respond better to olokizumab than to a placebo and non-inferior to...
Graded sensorimotor retraining intervention may help relieve chronic backache: JAMA Dr. Kamal Kant Kohli5 Aug 2022 7:30 PM ISTPeople challenged with chronic back pain have been given hope with a new treatment that focuses on retraining how the back and the brain communicate,...
Zuranolone found effective for postpartum depression in phase 3 study Dr. Kamal Kant Kohli6 Jun 2022 9:15 AM ISTCAMBRIDGE, Mass: Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that the Phase 3 SKYLARK Study of zuranolone,...
Trial that finds Vitamin D does not prevent type 2 diabetes in high risk adults Dr B.P. RAHUL27 May 2022 6:15 PM ISTThe results of the trial showed that supplements had no clinically meaningful effect in high-risk adults, but suggest there may be a benefit for...
